Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • dsher
    Member
    • Feb 2013
    • 23

    Hybrid assembly with low coverage PacBio libraries

    Hi everyone,

    We are working on sequencing the genomes of a few bacteria and microalgae. We recently had a PacBio run which provided pretty bad results (only 76 MB of data - ~15x coverage of our ~4.5MB genome, average read length ~5,800 bp) which could not be assembled into anything coherent using HGAP. Canu assembler provided what looked like better results (106-110 contigs, N50 ~23kb) but these still covered less than one-half of the expected genome size (sum of contig length was ~2.3 MB, and our genome is estimated at ~4.5MB).

    Given that we are having issues with getting high-quality DNA for PacBio from some of our cultures, we were thinking of making an Illumina library to use these reads for a hybrid assembly. Does anyone have any experience with using such a hybrid method with low-coverage PacBio data? Specifically, are there any recommended tools or parameters suggested for such an assembly?

    One point to keep in mind is that our microalgae cultures are not axenic so we expect a (low) level of contaminating DNA.

    Any recommendations will be very helpful.

    Thanks
    Daniel
  • capricy
    Senior Member
    • Apr 2012
    • 125

    #2
    Hi, Daniel,

    I have similar question. My illumina reads assembly covered about 50% of the genome. Do you have some updated ideas to share?

    Thanks.

    C

    Comment

    • dsher
      Member
      • Feb 2013
      • 23

      #3
      Hi Capricy - no updated ideas yet... How do you know your Illumina assembly covers only 50% of the genome? What kind of libraries did you use, and what coverage did you get on the assembled parts?
      Cheers
      Daniel

      Comment

      • capricy
        Senior Member
        • Apr 2012
        • 125

        #4
        The data were from E coli. New isolates. Library is illumina miseq. Coverage was estimated from the assembly/reference alignment.

        Comment

        • dsher
          Member
          • Feb 2013
          • 23

          #5
          I don't know much about the genomics of different E. coli strains but isn't that coverage relatively low? If you just mapped the reads to one or more of the known E. coli genomes, what coverage would you get? That might help you see whether you have a very weird genome (e.g. very large genomic islands which do not map to your reference sequence) or whether your assembly isn't very good. With our larger cyanobacterial genomes I think the low coverage is because the PacBio assembly isn't very good.

          BTW we recently published a comparative analysis of what you get when you close a genome compared to fragmented de-novo assemblies for a different heterotrophic bacterium (http://journal.frontiersin.org/artic...016.00248/full). This has some information on the number of sequences and coverage we got that might be worth comparing with your results.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM
          • GATTACAT
            Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
            by GATTACAT
            Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
            07-01-2026, 11:43 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          24 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-09-2026, 10:04 AM
          0 responses
          34 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-08-2026, 10:08 AM
          0 responses
          21 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-07-2026, 11:05 AM
          0 responses
          34 views
          0 reactions
          Last Post SEQadmin2  
          Working...